Promethazine Suppository Dosing for a 3-Year-Old Child (14.52 kg)
Do not give promethazine suppositories to this child—promethazine is contraindicated in children under 2 years of age due to risk of fatal respiratory depression, and use in children aged 2 years and older requires extreme caution with weight-based dosing of 0.5 mg/kg, which would be approximately 7.25 mg for this child, but no commercial suppository exists in this dose.
Critical Safety Considerations
Black Box Warning
Promethazine carries an FDA black box warning specifically prohibiting use in children under 2 years of age due to fatal respiratory depression 1. While your 3-year-old patient is technically above this age cutoff, the drug remains high-risk in young children and requires careful consideration 2.
Dosing Challenges
Weight-based calculation:
- FDA-approved dosing: 0.5 mg per pound (approximately 1.1 mg/kg) of body weight 1
- For 14.52 kg (32 lb): approximately 7.25-7.5 mg would be the calculated dose
- Problem: Commercial suppositories come in 12.5 mg, 25 mg, and 50 mg strengths only 3, 4, 5
The smallest available suppository (12.5 mg) exceeds the appropriate weight-based dose for this child by nearly 70%.
Available Suppository Strengths and Appropriateness
- 12.5 mg suppository: Too high for a 14.52 kg child (would deliver 0.86 mg/kg vs recommended 0.5 mg/kg)
- 25 mg suppository: Grossly excessive and dangerous
- 50 mg suppository: Absolutely contraindicated
Pharmacokinetic Concerns
Suppositories have highly variable absorption with:
- Individual bioavailability ranging from 4% to 343% 3
- Mean time to peak concentration of 6.7-8.6 hours 3
- Lower peak concentrations but prolonged absorption compared to oral formulations 3, 4
This unpredictable absorption pattern makes overdosing particularly dangerous in young children.
Documented Risks in Pediatric Patients
Respiratory depression has been documented even at recommended doses:
- One case series reported respiratory arrest in a child receiving 0.07 mL/kg of a meperidine-promethazine-chlorpromazine combination (promethazine component: ~0.45 mg/kg) 6
- Adverse effects include sedation, agitation, hallucinations, seizures, dystonic reactions, and possible SIDS 7
- Contemporary safety reviews recommend progressive restriction or elimination of promethazine use in pediatrics 8, 9
Safer Alternative Approach
If antiemetic/sedation is needed:
- Ondansetron (5-HT3 antagonist): 0.15 mg/kg IV/oral (max 8 mg) - superior safety profile
- Metoclopramide: 0.1-0.2 mg/kg IV/oral (max 10 mg) - if gastroparesis suspected
- Dimenhydrinate: 1-1.5 mg/kg oral/rectal every 6-8 hours (max 50 mg/dose) - for motion sickness
If promethazine is absolutely necessary despite risks:
- Use oral syrup formulation at 0.5 mg/kg (7.25 mg for this child)
- Syrup allows precise weight-based dosing unavailable with suppositories
- Provides more predictable pharmacokinetics than rectal route 3
- Monitor continuously for respiratory depression for at least 2 hours post-dose
Clinical Pitfalls to Avoid
- Never split or cut suppositories - uneven drug distribution makes accurate dosing impossible
- Never use adult dosing (12.5-25 mg) in young children regardless of indication
- Never combine with other sedating medications without intensive monitoring
- Never use for unknown causes of vomiting in children 1
The lack of appropriately sized suppository formulations for this weight range, combined with the drug's serious safety concerns and highly variable rectal absorption, makes promethazine suppositories unsuitable for this 3-year-old child.